IBIO Stock Analysis: Buy, Sell, or Hold?
IBIO - iBio, Inc. Common Stock
$1.64
-0.13 (-7.34%)
▼
5d:
-2.96%
30d:
-26.79%
90d:
-23.72%
HOLD
MODERATE Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 01, 2026
0d
Get Alerted When IBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called IBIO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IBIO is currently trading at $1.64, which is considered slightly low relative to its 30-day fair value range of $1.69 to $2.12.
Technical Outlook: Technically, IBIO is in a downtrend. Immediate support is located at $1.52, while resistance sits at $1.85. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: IBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.37 (+227.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IBIO is in a downtrend. Immediate support is located at $1.52, while resistance sits at $1.85. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: IBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.37 (+227.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.69 -
$2.12
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.3%)
- BULLISH: Trading 227.2% below Wall St target ($5.37)
Trading Range Analysis
30-Day Trading Range
$1.69 -
$2.12
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.52
Resistance Level
$1.85
Current Trend
Downtrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.66
Wall Street Target
$5.37
(+227.2%)
Revenue Growth (YoY)
14.3%
Share & Embed Analysis
Last updated: May 08, 2026 8:21 AM ET
Data refreshes hourly during market hours. Next update: 9:21 AM
Data refreshes hourly during market hours. Next update: 9:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IBIO showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Felipe Duran
BUY
24835 shares
2026-03-19
Martin Brenner
BUY
12336 shares
2026-03-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$100 | 69 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 67 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 55 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$174 | 63 BUY |
